Wuhan Thalys Med Tech Co Ltd (603716) — Cash Flow Quality Index
Wuhan Thalys Med Tech Co Ltd (603716) has a Cash Flow Quality Index of -8.60x as of March 2024. Operating cash flow of CN¥-27.15 Million is below net income of CN¥3.16 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 603716 operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Wuhan Thalys Med Tech Co Ltd Cash Flow Quality Index (2011–2020)
Historical Cash Flow Quality Index for Wuhan Thalys Med Tech Co Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Wuhan Thalys Med Tech Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Wuhan Thalys Med Tech Co Ltd (2011–2020)
Year-by-year earnings quality comparison for Wuhan Thalys Med Tech Co Ltd. For live market cap and the full company financial profile, see Wuhan Thalys Med Tech Co Ltd (603716) total market value.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 0.12x | CN¥9.94 Million | CN¥82.03 Million | ▼ -81.6% |
| 2019 | 0.66x | CN¥93.92 Million | CN¥142.44 Million | ▲ +220.3% |
| 2018 | -0.55x | CN¥-63.83 Million | CN¥116.43 Million | ▲ +7.6% |
| 2017 | -0.59x | CN¥-63.25 Million | CN¥106.58 Million | ▼ -156.5% |
| 2016 | -0.23x | CN¥-17.02 Million | CN¥73.55 Million | ▼ -132.3% |
| 2015 | 0.72x | CN¥46.11 Million | CN¥64.31 Million | ▲ +37.3% |
| 2014 | 0.52x | CN¥30.07 Million | CN¥57.58 Million | ▼ -18.4% |
| 2013 | 0.64x | CN¥32.54 Million | CN¥50.86 Million | ▲ +782.5% |
| 2012 | 0.07x | CN¥2.70 Million | CN¥37.23 Million | ▲ +111.0% |
| 2011 | -0.66x | CN¥-24.22 Million | CN¥36.64 Million | — |